Stem Cell Theranostics
A biotechnology company founded in 2013 that develops technology to treat heart disease using pluripotent stem cells. Disease in a dish and clinical trial in a dish platforms are used to develop cardiovascular drugs and perform cardio-toxicity safety testing for non-cardiovascular drugs.
All edits
Stem Cell Theranostics is a biotechnology company using stem cells to treat cardiovascular diseases that is headquartered in Redwood City, California and was founded in 2013 by Anderw Lee.
On January 1, 2014 Stem Cell Theranostics completed their series A funding round with $5.5 million in funding from Bill Marcus.
Divya NagDivya Nag and fellow student Andrew Lee started Stem Cell Theranostics with their professors. Nag is no longer with Stem Cell Theranostics, and has started StartX Med, a medical arm of Standford Student Enterprises Labs and now works for Apple in the Health Special Projects section.
Find more companies like Stem Cell Theranostics
